Average Co-Inventor Count = 9.17
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (30 from 2,405 patents)
2. Merck + Co., Inc. (2 from 4,770 patents)
3. Merck Canada Inc. (1 from 40 patents)
32 patents:
1. 12180226 - Spirotricycle RIPK1 inhibitors and methods of uses thereof
2. 12030872 - N-heteroaryl indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
3. 11230547 - Purine inhibitors of human phosphatidylinositol 3-kinase delta
4. 11179389 - Purine inhibitors of human phosphatidylinositol 3-kinase delta
5. 11174248 - Indazolyl-spiro[2.3]hexane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
6. 11161854 - Indazolyl-spiro[2.2]pentane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
7. 10544147 - Purine inhibitors of human phosphatidylinositol 3-kinase delta
8. 10221178 - Purine inhibitors of human phosphatidylinositol 3-kinase delta
9. 9938281 - Purine inhibitors of human phosphatidylinositol 3-kinase delta
10. 9884048 - ERK inhibitors
11. 9730940 - Purine inhibitors of human phosphatidylinositol 3-kinase delta
12. 9469615 - [object Object]
13. 9290453 - [object Object]
14. 9233979 - Compounds that are ERK inhibitors
15. 9221809 - Aminopyrimidinones as interleukin receptor-associated kinase inhibitors